Correlation Engine 2.0
Clear Search sequence regions

  • alleles (1)
  • anion (2)
  • cholesterol (1)
  • genes (1)
  • genes expressed (1)
  • humans (1)
  • impaired (2)
  • liver (4)
  • phases (4)
  • prodrugs (1)
  • sodium (2)
  • Sizes of these terms reflect their relevance to your search.

    The liver plays a pivotal role in drug handling due to its contribution to the processes of detoxification (phases 0 to 3). In addition, the liver is also an essential organ for the mechanism of action of many families of drugs, such as cholesterol-lowering, antidiabetic, antiviral, anticoagulant, and anticancer agents. Accordingly, the presence of genetic variants affecting a high number of genes expressed in hepatocytes has a critical clinical impact. The present review is not an exhaustive list but a general overview of the most relevant variants of genes involved in detoxification phases. The available information highlights the importance of defining the genomic profile responsible for the hepatic handling of drugs in many ways, such as (i) impaired uptake, (ii) enhanced export, (iii) altered metabolism due to decreased activation of prodrugs or enhanced inactivation of active compounds, and (iv) altered molecular targets located in the liver due to genetic changes or activation/downregulation of alternative/compensatory pathways. In conclusion, the advance in this field of modern pharmacology, which allows one to predict the outcome of the treatments and to develop more effective and selective agents able to overcome the lack of effect associated with the existence of some genetic variants, is required to step forward toward a more personalized medicine.


    Jose J G Marin, Maria A Serrano, Maria J Monte, Anabel Sanchez-Martin, Alvaro G Temprano, Oscar Briz, Marta R Romero. Role of Genetic Variations in the Hepatic Handling of Drugs. International journal of molecular sciences. 2020 Apr 20;21(8)

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32326111

    View Full Text